Evidence map›Paper›PMID 25746046›Full record

ReviewCritical reviews in immunology2015

Orchestration of invariant natural killer T cell development by E and Id proteins.

Sumedha Roy, Yuan Zhuang

Abstract readReview
In one paragraph

Review in Critical reviews in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. The Function of E2A in B-Cell Development.Advances in experimental medicine and biology · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors.Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sumedha RoyDepartment of Immunology, Duke University Medical Center, Durham, NC 27710.
Yuan ZhuangDepartment of Immunology, Duke University Medical Center, Durham, NC 27710.

Funding

The role of TCR, ligand, and signal strength in human γδ T cell developmentP01AI102853 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI CORNELIS MURRE · 2014 to 2026
$26.3M
HEB MEDIATED PATHWAYS AND FUNCTION IN T CELL DEVELOPMENTR01GM059638 · NIGMS · DUKE UNIVERSITY · PI CHAN, FRANCIS KAMING · 1999 to 2021
$6.9M
NIAID NIH HHS 1 P01 AI102853NIAID NIH HHS P01 AI102853NIGMS NIH HHS GM R01 GM059638NIGMS NIH HHS R01 GM059638
6 · The paper itself

Abstract

Natural killer T (NKT) cells are αβ T cells that express a semi-invariant T-cell receptor (TCR) along with natural killer (NK) cell markers and have an innate cell-like ability to produce a myriad of cytokines very quickly upon antigen exposure and subsequent activation. These cells are diverted from conventional single positive (SP) T-cell fate at the double positive (DP) stage, where TCR-mediated recognition of a lipid antigen presented on a CD1d molecule promotes their selection into the NKT lineage. Although many key regulatory molecules have been shown to play important roles in the development of NKT cells, the mechanism of lineage specification and acquisition of effector functions in these cells still remain to be fully addressed. In this review, we specifically discuss the role of a family of class-I helix-loop-helix proteins known as E proteins, and their antagonists Id proteins in NKT celldevelopment. Recent work has shown that these proteins play key roles in invariant NKT (iNKT) development, from the invariant TCR rearrangement to terminal differentiation and maturation. Elucidating these roles provides an opportunity to uncover the transcriptional network that separates NKT cells from concurrently developed conventional αβ T cells.

Indexed as

AnimalsAntigens, CD1dBasic Helix-Loop-Helix ProteinsCell DifferentiationCell LineageHumansImmunity, InnateInhibitor of Differentiation Protein 1Natural Killer T-CellsT-LymphocytesAntigens, CD1dBasic Helix-Loop-Helix ProteinsID1 protein, humanInhibitor of Differentiation Protein 1

Identifiers

PMID25746046
PMCPMC4553236

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.